Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Sep 16, 2024; 16(9): 526-532
Published online Sep 16, 2024. doi: 10.4253/wjge.v16.i9.526
Published online Sep 16, 2024. doi: 10.4253/wjge.v16.i9.526
Country/region of origin | Amoxicillin resistance (n = 68) | Clarithromycin resistance (n = 70) | Metronidazole resistance (n = 63) | Levofloxacin resistance (n = 45) | Tetracycline resistance (n = 58) |
United States | 3/11 (27.27) | 1/11 (9.09) | 1/10 (10.00) | 0/6 (0.00) | 0/9 (0.00) |
Mexico | 4/45 (8.89) | 12/46 (26.09) | 6/43 (13.95) | 11/31 (35.48) | 0/38 (0.00) |
Central and South America | 0/9 (0.00) | 2/9 (22.22) | 1/8 (12.50) | 3/6 (50.00) | 0/7 (0.00) |
Asia | 0/1 (0.00) | 0/2 (0.00) | 0/0 (0.00) | 0/1 (0.00) | 0/3 (0.00) |
Other | 0/2 (0.00) | 0/2 (0.00) | 0/2 (0.00) | 0/1 (0.00) | 0/1 (0.00) |
Total | 7/68 (10.29) | 15/70 (21.43) | 8/63 (12.70) | 14/45 (31.11) | 0/58 (0.00) |
- Citation: Tabesh A, Antillon RA, Kondradzhyan M, Tan AZ. Prevalence and resistance of Helicobacter pylori in a predominantly Hispanic population. World J Gastrointest Endosc 2024; 16(9): 526-532
- URL: https://www.wjgnet.com/1948-5190/full/v16/i9/526.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i9.526